UNISOUND (09678) saw its shares rise more than 10% during the trading session. As of the latest update, the stock was up 9.52%, trading at HK$319.6, with a turnover of HK$338 million. On the news front, a research report from ZS Group highlighted that UNISOUND's core medical data has built a solid industry barrier. The company is penetrating core diagnostic and treatment scenarios through its medical large models and various AI agents, having established collaborations with top-tier hospitals such as Peking Union Medical College Hospital, Beijing Friendship Hospital, and Xiangya Hospital in Hunan. Its services now cover 40% of the top 100 tertiary hospitals in China. The report stated that these cutting-edge and professional massive data assets in vertical sectors will form the company's core competitive advantage. Leveraging high-quality data training, UNISOUND has established an efficient data flywheel effect. Furthermore, its extensive, high-quality data holds significant application potential in reducing costs for medical insurance and commercial health insurance. The institution forecasts that UNISOUND's revenue will accelerate over the next three years, with projected revenues for 2025-2027 reaching RMB 1.236 billion, RMB 1.923 billion, and RMB 2.918 billion, respectively, representing growth rates of 31.6%, 55.6%, and 51.7%. The company is expected to achieve profitability in 2026. Considering the verified growth of UNISOUND's large model business and the considerable potential in AI clinical diagnosis and medical insurance cost reduction applications, a 2026 price-to-sales (PS) ratio valuation of 25 times is applied, yielding a target price of HK$750.58.